Embla Medical

In 2025, Embla Medical hf reported total carbon emissions of approximately 221.8 million kg CO2e. This figure includes Scope 1 emissions of about 15.9 million kg CO2e, Scope 2 emissions of approximately 10.9 million kg CO2e, and Scope 3 emissions of around 293.4 million kg CO2e. The company has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its value chain by 2050.

Embla Medical has established near-term targets to reduce absolute Scope 1 and 2 emissions by 79% by 2030 from a 2019 baseline, and to cut Scope 3 emissions by 25% by 2030 from a 2021 baseline. Long-term goals include a 90% reduction in both Scope 1 and 2 emissions by 2050, as well as a 90% reduction in Scope 3 emissions by the same year. These targets align with the Science Based Targets initiative (SBTi) and reflect the company's commitment to sustainable practices within the healthcare equipment and supplies sector.

Embla Medical's headquarters is located in Iceland, and it is part of a corporate family that includes Össur hf., which shares similar climate commitments and targets.